title: How do we continue treatment in patients with type 2 diabetes when therapeutic goals are not reached with oral antidiabetes agents and lifestyle? Incretin versus insulin treatment.
authors.affiliation: Department of Medicine IV, Eberhard-Karls University, Tübingen, Germany. baptist.gallwitz@med.uni-tuebingen.de
authors.forename: Baptist
authors.initials: B
authors.lastname: Gallwitz
authors.forename: Reinhard G
authors.initials: RG
authors.lastname: Bretzel
mesh_terms: D000284:Administration, Oral; D003131:Combined Modality Therapy; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D054795:Incretins / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D008019:Life Style; D010347:Patient Care Planning; D018802:Patient-Centered Care / Q000379:methods; D040242:Risk Reduction Behavior
chemical_list: D007004:Hypoglycemic Agents; D054795:Incretins; D007328:Insulin